Search
+
    SEARCHED FOR:

    TORRENT PHARMACEUTICALS STOCKS

    Stocks in news: BHEL, Chetan Rajpara, Kalpataru Projects, Torrent Pharma, Century Textiles

    Indian equity markets are witnessing dynamic movements with substantial swings. Shares of BHEL, Chetan Rajpara, Kalpataru Projects, Torrent Pharma, Century Textiles, and others will be in focus today. Updates on Force Motors, Bharat Heavy Electricals Limited, Uno Minda, NBCC, and Coal India. News on Mirzapur Thermal Energy, Sun Pharma Advanced Research Company, Inovance Automotive, Birla Estates, and Takeda Pharmaceuticals.

    These 3 stocks showing RSI Trending Up on May 27
    Torrent Pharma, Glenmark Pharma shares jump up to 9% after Q4 results

    Shares of Torrent Pharma and Glenmark Pharma surged post Q4 results. Torrent Pharma's net profit jumped 56% YoY while Glenmark Pharma reported increased losses. Motilal Oswal provides target prices for both companies.

    Stocks with tailwinds called advantage India: 5 largecap stocks from 3 different sectors with an upside potential of upto 36 %

    In terms of valuations and sentiment we are not far from the place where we were in the last quarter of 2023 or early part of this year. When it was not possible to find stocks which can be called as “fairly valued” forget “undervalued”, and the sentiment was very bullish. The only difference between then and now is that we have election results which are coming up. Surely a confirmation on 4th June that continuity in the policy making is a big factor. But there is another thing which long term investors need to look at before investing. Whether the company or the sector has an advantage due to India as a country. A well known example, which has been present for decades is that of the IT industry. India as a country is a factory of software engineers, and that is our strength. So when investing for the long term, look at sectors where we have some strong tailwinds due to our human capital.

    Stocks in news: NTPC, Cochin Shipyard, Hindustan Copper, Karnataka Bank, Narayana Hrudayalaya

    Torrent Pharmaceuticals consolidated net profit surged 56.45% to Rs 449 crore in Q4 FY24 as compared with Rs 287 crore recorded in Q4 FY23. Revenue from operations rose 10.2% YoY to Rs 2,745 crore in the quarter ended 31 March 2024.

    Torrent Pharma board approves to raise Rs 5,000 crore

    Torrent Pharmaceuticals, actively seeking to expand through acquisitions, has expressed interest in purchasing Mumbai-based pharmaceutical company JB Pharma, according to a report by ET on Friday.

    The Economic Times
    BACK TO TOP